Arkolith/Insider Trading/EDIT/Form 4

Robertson Michelle

EVP, CHIEF FINANCIAL OFFICEREditas Medicine, Inc. (EDIT) · full profile →Form 4 · filed Mar 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 3, 2023Sell(S)184$8.89$2K108K
Mar 2, 2023Grant(A)32K—$0108K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2023Grant(A)95K—$095K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-004315) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML